Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
This is an important, interesting and useful paper. Four typical applications of Bayesian methods in pharmaceutical research are outlined. The authors consider: 1. LD 50 experiments and the special problems which arise first from trend towards small experiments, and secondly from proposed changes in the form of reporting the analysis of such experiments. 2. The controversy over the use of cross-over designs - currently very widely employed - in situations where there may be carryover effects. 3. The problem of the efficient use of the data and experimental resources in the area of bioequivalence assessment, and 4. The analysis of the ``nonlinear random effects models, which underlie population pharmacokinetics and pharmacodynamic studies.
- On Bayesian Methods for Bioequivalence
- Bayesian methods in pharmaceutical research
- The Bayesian approach to population pharmacokinetic/pharmacodynamic modeling
- Applied statistics in the pharmaceutical industry. With case studies using S-PLUS
- Hierarchical Bayesian analysis of the carryover effect in two-period crossover designs
- A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
- An approach to evaluating sensitivity in Bayesian regression analyses. (With discussion)
- Clinician preferences and the estimation of causal treatment differences. (With comments)
- Hierarchical Bayesian analysis of the carryover effect in two-period crossover designs
- Biostatistics and Bayes. With comments and a rejoinder by the author
- On large-sample parametric approaches for interval estimation of the \(ED_{90}\)
- Goodness of fit for the logistic regression model using relative belief
- Approximation of Bayesian predictive \(p\)-values with regression ABC
- Incorporating Bayesian ideas into health-care evaluation
- Bayesian tests for the balanced two-way analysis of variance model
- The Wasserstein impact measure (WIM): a practical tool for quantifying prior impact in Bayesian statistics
- Prediction markets, Bayesian priors, and clinical trials
- Bayesian modelling of a pharmaceutical experiment with heterogeneous responses
- Asymptotic properties of anoya bayes factors
- Extended Models for Quantal Response Data
- On the multivariate predictive distribution of multi-dimensional effective dose: a Bayesian approach
- Critical issues in different inferential paradigms
- Estimating treatment effects in clinical crossover trials
- Kullback-leibler information approach to the optimum measurement point for bayesian estimation
- A Bayesian Approach for Nonlinear Regression Models with Continuous Errors
- Weak informativity and the information in one prior relative to another
- A Bayesian Approach to Finite Mixture Models in Bioassay via Data Augmentation and Gibbs Sampling and Its Application to Insecticide Resistance
- Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
- Population Pharmacokinetic/Pharmacodynamic Methodology and Applications: A Bibliography
- Constructing Release Targets for Drug Products: A Bayesian Decision Theory Approach
- A Bayesian approach to pharmaceutical product quality risk quantification
- Bayesian index to compare assumed survival functions of two hazards following exponential distributions
- Bayesian methods in pharmaceutical research
- Bayesian methods for analysing ringing data
- Using History Matching for Prior Choice
- A conversation with Amy Racine-Poon
- Variational Inference based on a Subclass of Closed Skew Normals
- A weakly informative default prior distribution for logistic and other regression models
This page was built for publication: Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3774792)